Health X Platform files FY26 BRSR with BSE and NSE exchanges

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Health X Platform filed its FY26 BRSR with BSE and NSE on September 4, 2026
  • Paid-up capital stands at ₹3181.05 lakhs with consolidated reporting basis
  • Wholesale pharmaceutical trading contributes 98.80% of total turnover
  • No assurance provider was engaged for the sustainability report
powered bylight_fuzz_icon
50062349

*this image is generated using AI for illustrative purposes only.

Health X Platform Limited submitted its Business Responsibility and Sustainability Report (BRSR) for FY26 to the Bombay Stock Exchange and National Stock Exchange on September 4, 2026. The filing provides consolidated disclosures on the company’s operational and sustainability metrics.

The report was filed pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It is also available on the company’s website. Pratap Singh, Company Secretary and Compliance Officer, signed the document.

General Disclosures

The listed entity, formerly known as Sastasundar Ventures Limited, was incorporated on June 6, 1989. Its registered and corporate office is located in Kolkata. The paid-up capital stands at ₹3181.05 lakhs. The reporting boundary for this BRSR is on a consolidated basis. No assurance provider was engaged for this report.

Detail Information
CIN L65993WB1989PLC047002
Paid-up Capital ₹3181.05 lakhs
Reporting Basis Consolidated
Assurance Provider Not Applicable

Business Activities

Wholesale trading of pharmaceutical and OTC products accounts for 98.80% of the entity’s turnover. Other financial service activities contribute a negligible 0.002%. The company operates under NIC codes 46497 and 46901 for its primary wholesale activities.

Activity % of Turnover
Wholesale of pharmaceutical/medical goods 98.80%
Other Financial Service activities 0.002%

Historical Stock Returns for Health X Platform

1 Day5 Days1 Month6 Months1 Year5 Years
+2.82%+2.30%-4.67%+7.42%+8.96%+2.72%

How might the lack of an independent assurance provider for this BRSR impact investor confidence in Health X's sustainability claims compared to peers?

Given that 98.8% of turnover comes from pharmaceutical wholesale, what specific sustainability risks related to supply chain logistics or regulatory compliance is the company prioritizing in FY27?

Will Health X Platform initiate a strategic pivot to diversify its revenue streams beyond wholesale trading to mitigate concentration risk in the coming fiscal years?

Health X Platform AGM seeks approval for ₹500 crore borrowing limit

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • AGM scheduled for September 28, 2026, via video conferencing
  • Shareholders to approve ₹500 crore overall borrowing limit
  • Reappointment of Mrs. Anjana Dikshit as Independent Director proposed
  • Revised CA certificate confirms >50% revenue from healthcare activities
powered bylight_fuzz_icon
50054604

*this image is generated using AI for illustrative purposes only.

Health X Platform will hold its 37th Annual General Meeting on September 28, 2026, via video conferencing. The agenda includes seeking shareholder approval for an overall borrowing limit of ₹500 crore and authorizing loans and guarantees up to ₹600 crore under Section 186 of the Companies Act, 2013.

The company also proposes creating mortgages or charges on assets to secure borrowings within the approved limits. Additionally, shareholders will vote on advancing loans or providing security to subsidiaries and group entities up to ₹200 crore under Section 185.

Governance and Director Reappointments

Mrs. Abha Mittal retires by rotation and offers herself for reappointment as a director. The Board recommends the reappointment of Mrs. Anjana Dikshit as an Independent Director for a second term of five years, from November 10, 2026, to November 9, 2031. Mrs. Dikshit serves on the Audit Committee and Stakeholders Relationship Committee.

Regulatory Compliance Update

The notice includes a revised certificate from statutory auditors JKVS & Co., dated April 9, 2026. This addresses stock exchange queries regarding revenue bifurcation for the name change from Sastasundar Ventures Limited to Health X Platform Limited. The certificate confirms that more than 50% of consolidated revenue comes from healthcare activities.

What the Numbers Show

The CA certificate discloses consolidated revenue figures for the period from January 1, 2025, to December 31, 2025. Healthcare activity generated ₹1,20,971.84 lakh, while financial services contributed ₹2,160.79 lakh. This results in total revenue of ₹1,23,132.63 lakh, with healthcare accounting for approximately 98% of the total, validating the regulatory requirement for the name change.

Meeting Details

Remote e-voting opens on September 25, 2026, at 9:00 am and closes on September 27, 2026, at 5:00 pm. The record date for voting rights is September 21, 2026. Mr. Raj Kumar Banthia has been appointed as the scrutinizer for the voting process.

Historical Stock Returns for Health X Platform

1 Day5 Days1 Month6 Months1 Year5 Years
+2.82%+2.30%-4.67%+7.42%+8.96%+2.72%

How will the approved ₹500 crore borrowing limit and ₹600 crore loan authorization accelerate Health X Platform's expansion into new healthcare segments or geographic markets?

What specific strategic initiatives or capital expenditures are the proposed loans to subsidiaries under Section 185 intended to fund?

Given that healthcare now constitutes 98% of revenue, how might investors' valuation multiples for Health X Platform shift compared to its previous classification as a diversified conglomerate?

More News on Health X Platform

1 Year Returns:+8.96%